The clinical course of a patient with pulmonary hypertension associated with Sjogren's syndrome is reported. The clinical features and outcome of this case are compared with those of two other reported cases in the Spanish and Japanese published work. Thus far, pulmonary hypertension has not been reported with primary Sjogren's syndrome in English publications. These three cases suggest that the development of pulmonary hypertension in primary Sjogren's syndrome is uncommon but should be included as part of the clinical spectrum.
This report describes a patient with a diagnosis of primary pulmonary hypertension in whom a diagnosis of Sjogren's syndrome was concomitantly made. These three cases are reviewed and compared with the features ofprimary pulmonary hypertension.
Case report
Two years before this presentation the patient, a 42 year old black woman, developed progressive dyspnoea following her last pregnancy. Ten months previously she was diagnosed as having primary pulmonary hypertension after an extensive cardiopulmonary evaluation including echocardiography, radionuclide perfusion lung scanning, pulmonary function testing, and cardiac catheterisation. With the exception of the sicca complex, there are few if any significant differences between the clinical aspects of these three cases and those reported in a recent review of primary pulmonary hypertension. 4 All three cases involved women of child bearing age. This is comparable with the age range and female preponderance noted in this cited review. The presenting cardiovascular symptoms, initial laboratory data, and clinical course were also similar. There were no features of any other connective tissue disease present in any of the patients.
The response to vasodilator therapy was poor in the three patients with Sjogren's syndrome, as it often is in primary pulmonary hypertension. Although one patient initially improved haemodynamically, no improvement in the length of survival was noted. In general the poor response to vasodilator therapy in these three patients suggests that reversible vasoconstriction was not the predominant pathogenic mechanism in their disease at that time.
It is difficult to make any correlation between the severities of the sicca symptoms and the degree of the pulmonary hypertension as the extent of the sicca symptoms varied considerably among the three patients.
In conclusion this report presents the first case recorded in the English published work of Sjogren's syndrome associated with primary pulmonary hypertension. The clinical course of the patient was compared with that of two other cases from the Spanish and Japanese published work who also had primary pulmonary hypertension, and no significant differences were noted. Although rare, primary pulmonary hypertension should be considered as part of the spectrum of pulmonary manifestations seen in Sjogren's syndrome. 
